Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HOXA9 and HOXA13 along with their shared gene targets act as common immune biomarkers in recurrent implantation failure and pre-eclampsia. | Hum Immunol | 2025 | 40020429 | PubTator, text mining | PubMed |
| Posttranscriptional activity of the eukaryotic translation initiation factor eIF4E contributes to HoxA9-driven leukemogenesis. | bioRxiv | 2025 | 39990322 | PubTator, text mining | PubMed |
| ChromaFactor: Deconvolution of single-molecule chromatin organization with non-negative matrix factorization. | PLoS Comput Biol | 2025 | 39965010 | PubTator, text mining | PubMed |
| HOXA9 methylation is not associated with survival in Brazilian patients with lung adenocarcinoma. | Clin Epigenetics | 2025 | 39962529 | PubTator, text mining | PubMed |
| DNA methylation biomarker analysis from low-survival-rate cancers based on genetic functional approaches. | Front Bioinform | 2025 | 39944136 | PubTator, text mining | PubMed |
| Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia. | BMC Cancer | 2025 | 39920624 | PubTator, text mining | PubMed |
| Extracellular Vesicles From Dental Pulp Cells Promote Osteogenic Differentiation in Periodontal Ligament Cells. | J Periodontal Res | 2025 | 39915250 | PubTator, text mining | PubMed |
| Protocol for the generation of HLF+ HOXA+ human hematopoietic progenitor cells from pluripotent stem cells. | STAR Protoc | 2025 | 39864063 | PubTator, text mining | PubMed |
| Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian Carcinoma. | Int J Mol Sci | 2025 | 39859203 | PubTator, text mining | PubMed |
| Oncogenic role of RARG rearrangements in acute myeloid leukemia resembling acute promyelocytic leukemia. | Nat Commun | 2025 | 39805831 | PubTator, text mining | PubMed |
| Gene Expression Profiles in Ovarian Cancer Tissues as a Potential Tool to Predict Platinum-based Chemotherapy Resistance. | Anticancer Res | 2025 | 39740837 | PubTator, text mining | PubMed |
| The role of the circ_DOCK1-miR-1297-HOXA9 regulatory network in the development of oral squamous cell carcinoma. | Pathol Res Pract | 2025 | 39721095 | PubTator, text mining | PubMed |
| TIFAB modulates metabolic pathways in KMT2A::MLLT3-induced AML through HNF4A. | Blood Adv | 2025 | 39626355 | PubTator, text mining | PubMed |
| Blood Plasma Methylated DNA Markers in the Detection of Lymphoma: Discovery, Validation, and Clinical Pilot. | Am J Hematol | 2025 | 39564730 | PubTator, text mining | PubMed |
| Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes. | Front Oncol | 2024 | 39834944 | PubTator, text mining | PubMed |
| [A two-site combined prediction model based on HOXA9 DNA methylation for early screening of risks of meningioma progression]. | Nan Fang Yi Ke Da Xue Xue Bao | 2024 | 39623266 | PubTator, text mining | PubMed |
Laparoscopic Salpingectomy Regulates The Expression of Endometrial Homeobox Genes (HOXA9, HOXA10, HOXA11, HOXD10) and HOX Transcript Antisense Intergenic RNA in Women with Communicating Hydrosalpinx: A Prospective Study. | Int J Fertil Steril | 2024 | 39564825 | PubTator, text mining | PubMed |
| NAT10-mediated mRNA N4-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemia. | Nat Cell Biol | 2024 | 39506072 | PubTator, text mining | PubMed |
| HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression. | Diagn Pathol | 2024 | 39462379 | PubTator, text mining | PubMed |
| EuDockScore: Euclidean graph neural networks for scoring protein-protein interfaces. | Bioinformatics | 2024 | 39441796 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=7